Research Article
Systemic Therapy of Neuroendocrine Neoplasia: Single Center Experience from a Cohort of 110 Consecutive Cases
Table 3
Chemotherapy regimens applied (number of cases; total n = 38).
| | Total | Histology | | Regimen | | G1 | G2 | G3 |
| | Carboplatin/etoposide | 18 | 0 | 2 | 16 | | Cisplatin/etoposide | 7 | 0 | 4 | 3 | | Streptozotocin/5-FU | 3 | 0 | 2 | 1 | | Temozolomide/capecitabine | 2 | 0 | 2 | 0 | | Temozolomide | 2 | 0 | 1 | 1 | | Carboplatin/irinotecan | 1 | 0 | 0 | 1 | | FOLFOX | 1 | 1 | 0 | 0 | | FOLFIRI | 1 | 0 | 0 | 1 | | Cyclophosphamide | 1 | 1 | 0 | 0 | | Dacarbazine | 1 | 0 | 1 | 0 | | Gemcitabine | 1 | 0 | 1 | 0 |
|
|
